Largest Shareholder ENCHEM Extends Pledge on 96% of Holdings: Risk of Forced Sale Crushing Stake to 0.58%
The largest shareholder ENCHEM has pledged 15.5 million shares (96% of its 14.53% stake) as collateral for operating loans. If enforced, ENCHEM's stake would plummet from 14.53% to 0.58%, triggering a change in control.
The pledge period has been extended from July 31 and May 29, 2026 to a uniform November 30, 2026, prolonging uncertainty. In case of default, the pledgee can execute forced sales under a 190% collateral maintenance condition.
Debtor ENCHEM recorded a net loss of 571.2 billion KRW in 2024, with total liabilities (660.1B) exceeding equity (466.8B), reflecting weak financial health. Further share price declines could trigger margin calls or forced liquidation.
ENCHEM previously subscribed to 22 billion KRW of convertible bonds (14th series) in July 2023, indicating a past capital support relationship, but the current pledge raises concerns over potential management disputes or governance changes.
[AI Comprehensive Analysis]This disclosure exposes the largest shareholder's extreme leverage and financial instability. Minority shareholders must consider persistent downside pressure from potential forced selling and risk of control change. Short-term negative impact on the stock price is likely; failure to secure additional collateral could lead to severe dilution.
KOSDAQ Filing Information
Filing: [Correction of Description] Execution of Stock Pledge Agreement Involving Change of Largest Shareholder